|
1) Ohtsuki Y, Nakanishi N, Fujita J, et al. Immuno-histochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias. Med Mol Morphol. 2007; 40: 163-7
|
|
|
|
2) Yokoyama A, Kondo K, Nakajima M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology. 2006; 11: 164-8
|
|
|
|
|
|
3) Takahashi H, Fujishima T, Koba H, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000; 162: 1109-14
|
|
|
|
|
|
4) Greene KE, King TE Jr, Kuroki Y, et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002; 19: 439-46
|
|
|
|
|
|
5) Takahashi H, Shiratori M, Kanai A, et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology. 2006; 11: S51-4
|
|
|
|
|
|
6) Kinder BW, Brown KK, McCormack FX, et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest. 2009; 135: 1557-63
|
|
|
|
|
|
7) 日本呼吸器学会, 編. 薬剤性肺障害の評価・治療についてのガイドライン. 東京: メディカルビュー社; 2006. p. 33-52
|
|
|
|
|
|
8) 高橋弘毅, 他. 間質性肺炎に対するcyclosporin A長期使用例の検討. 厚生労働科学研究: 特発性肺線維症の予後改善を目指したサイクロスポリン＋ステロイド治療ならびにNアセチルシステイン吸入療法に関する臨床研究班 平成19年度班研究報告書. 2008. p. 32-6
|
|
|
|
|
|
9) Kumánovics G, Minier T, Radics J, et al. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. Clin Exp Rheumatol. 2008; 26: 414-20
|
|
|
|
|
|
10) Hant FN, Ludwicka-Bradley A, Wang HJ, et al. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009; 36: 773-80
|
|
|
|
|
|
11) Takahashi H, Kuroki Y, Tanaka H, et al. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med. 2000; 162: 258-63
|
|
|
|
|
|
12) Asano Y, Ihn H, Yamane K, et al. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum. 2001; 44: 1363-9
|
|
|
|
|
|
13) Yanaba K, Hasegawa M, Takehara K, et al. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with syste-mic sclerosis as markers for monitoring the activity of pulmonary fibrosis. J Rheumatol. 2004; 31: 1112-20
|
|
|
|
|
|
14) 高橋弘毅, 他. 間質性肺炎における抗SP-D自己抗体. 厚生労働科学研究: びまん性肺疾患に関する調査研究班 平成19年度班研究報告書. 2008. p. 75-80
|
|
|
|
|